Sartorius AG (XTER:SRT) Beginning Cash Position : €379 Mil (As of Mar. 2024)

View and export this data going back to 1990. Start your Free Trial

What is Sartorius AG Beginning Cash Position?

Sartorius AG's Beginning Cash Position for the quarter that ended in Mar. 2024 was €379 Mil.

Sartorius AG's quarterly Beginning Cash Position increased from Sep. 2023 (€162 Mil) to Dec. 2023 (€294 Mil) and increased from Dec. 2023 (€294 Mil) to Mar. 2024 (€379 Mil).

Sartorius AG's annual Beginning Cash Position increased from Dec. 2021 (€204 Mil) to Dec. 2022 (€343 Mil) but then declined from Dec. 2022 (€343 Mil) to Dec. 2023 (€166 Mil).

Sartorius AG Beginning Cash Position Historical Data

The historical data trend for Sartorius AG's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Beginning Cash Position Chart

Sartorius AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

47.64

54.44

203.80

342.80

165.90

Sartorius AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															166.00	152.20	162.20	293.90	379.20

Sartorius AG Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Sartorius AG Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius AG (XTER:SRT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (XTER:SRT) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

SOAGY:USA SSSGY:USA SUVPF:USA SARTF:USA 1SRT3:Italy SRT3d:UK 0NIR:UK SRT3:Germany SRT3:Austria

Address

Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079

Website

https://www.sartorius.com

Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.